Esoron-D Capsule SR is a combination medication containing Domperidone 30mg and Esomeprazole 40mg, formulated to provide effective relief from gastrointestinal disorders. Domperidone is a prokinetic agent that enhances gastrointestinal motility by blocking dopamine receptors, thereby facilitating faster gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor (PPI), works by suppressing gastric acid secretion, promoting healing of acid-related damage in the stomach and esophagus, and providing relief from conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The sustained-release (SR) formulation ensures a gradual and prolonged release of the active ingredients, improving therapeutic efficacy and patient compliance by reducing dosing frequency. Esoron-D Capsule SR is indicated for the management of acid reflux, dyspepsia, gastritis, and other acid-related gastrointestinal ailments where both acid suppression and enhanced gastric motility are required. It should be used under medical supervision, especially in patients with liver or kidney impairment, and is contraindicated in individuals with known hypersensitivity to its components. Common side effects may include headache, dry mouth, or abdominal discomfort. This combination therapy offers a comprehensive approach to managing upper gastrointestinal symptoms by addressing both acid secretion and motility disturbances.